Literature DB >> 35704239

Elevation of major constitutive heat shock proteins is heat shock factor independent and essential for establishment and growth of Lgl loss and Yorkie gain-mediated tumors in Drosophila.

Gunjan Singh1, Saptomee Chakraborty1,2, Subhash C Lakhotia3.   

Abstract

Cancer cells generally overexpress heat shock proteins (Hsps), the major components of cellular stress response, to overcome and survive the diverse stresses. However, the specific roles of Hsps in initiation and establishment of cancers remain unclear. Using loss of Lgl-mediated epithelial tumorigenesis in Drosophila, we induced tumorigenic somatic clones of different genetic backgrounds to examine the temporal and spatial expression and roles of major heat shock proteins in tumor growth. The constitutively expressed Hsp83, Hsc70 (heat shock cognate), Hsp60 and Hsp27 show elevated levels in all cells of the tumorigenic clone since early stages, which persists till their transformation. However, the stress-inducible Hsp70 is expressd only in a few cells at later stage of established tumorous clones that show high F-actin aggregation. Intriguingly, levels of heat shock factor (HSF), the master regulator of Hsps, remain unaltered in these tumorous cells and its down-regulation does not affect tumorigenic growth of lgl- clones overexpressing Yorkie, although down-regulation of Hsp83 prevents their survival and growth. Interestingly, overexpression of HSF or Hsp83 in lgl- cells makes them competitively successful in establishing tumorous clones. These results show that the major constitutively expressed Hsps, but not the stress-inducible Hsp70, are involved in early as well as late stages of epithelial tumors and their elevated expression in lgl- clones co-overexpressing Yorkie is independent of HSF.
© 2022. The Author(s), under exclusive licence to Cell Stress Society International.

Entities:  

Keywords:  Activated Ras; DCP-1; HSF; Hsp70; Hsp83; Somatic clones

Mesh:

Substances:

Year:  2022        PMID: 35704239      PMCID: PMC9346025          DOI: 10.1007/s12192-022-01283-z

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.827


  57 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Genes affecting cell competition in Drosophila.

Authors:  David M Tyler; Wei Li; Ning Zhuo; Brett Pellock; Nicholas E Baker
Journal:  Genetics       Date:  2006-11-16       Impact factor: 4.562

Review 3.  Tumor progression and metastasis.

Authors:  J Yokota
Journal:  Carcinogenesis       Date:  2000-03       Impact factor: 4.944

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Separate regulatory elements for the heat-inducible and ovarian expression of the Drosophila hsp26 gene.

Authors:  R S Cohen; M Meselson
Journal:  Cell       Date:  1985-12       Impact factor: 41.582

Review 6.  Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach.

Authors:  Suman Chatterjee; Timothy F Burns
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

Review 7.  Drosophila melanogaster: A Model Organism to Study Cancer.

Authors:  Zhasmine Mirzoyan; Manuela Sollazzo; Mariateresa Allocca; Alice Maria Valenza; Daniela Grifoni; Paola Bellosta
Journal:  Front Genet       Date:  2019-03-01       Impact factor: 4.599

Review 8.  Heat Shock Proteins and HSF1 in Cancer.

Authors:  Anna M Cyran; Anatoly Zhitkovich
Journal:  Front Oncol       Date:  2022-03-02       Impact factor: 5.738

Review 9.  Mechanism of tumor-suppressive cell competition in flies.

Authors:  Hiroshi Kanda; Tatsushi Igaki
Journal:  Cancer Sci       Date:  2020-08-01       Impact factor: 6.716

10.  Targeting heat shock protein 90 for anti-cancer drug development.

Authors:  Anthony Aswad; Tuoen Liu
Journal:  Adv Cancer Res       Date:  2021-04-20       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.